Clinical Trials Browser

Phase 3 × Piebaldism × Imatinib Mesylate × Clear all

NCT05970900 2023-08-01

PIRKER

Phase 3 Not yet recruiting

GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors